REG-BARCLAYS PLC FORM 8.3 - AON PLC
06/01/2021 16:05
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210106:nBw7nWGvha&default-theme=true
FORM 8.3 - AON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 05 January 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
381,083 0.17% 3,138,359 1.37%
(2) Derivatives (other than options):
922,083 0.40% 34,258 0.01%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4) TOTAL:
1,303,166 0.57% 3,172,617 1.39%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 204.5300 USD
Purchase 4 204.7700 USD
Purchase 12 203.6320 USD
Purchase 28 204.2585 USD
Purchase 30 204.3320 USD
Purchase 33 204.2293 USD
Purchase 38 204.3752 USD
Purchase 47 204.4961 USD
Purchase 81 203.0616 USD
Purchase 85 204.8005 USD
Purchase 100 203.6900 USD
Purchase 102 204.3370 USD
Purchase 106 204.9861 USD
Purchase 232 205.8956 USD
Purchase 300 204.0366 USD
Purchase 306 203.6823 USD
Purchase 401 204.7780 USD
Purchase 404 205.0622 USD
Purchase 500 204.4390 USD
Purchase 528 204.8900 USD
Purchase 591 205.4780 USD
Purchase 604 205.0318 USD
Purchase 1,028 204.8885 USD
Purchase 1,221 204.7500 USD
Purchase 1,312 204.9252 USD
Purchase 1,370 204.7824 USD
Purchase 1,377 204.7387 USD
Purchase 1,630 204.8376 USD
Purchase 1,646 204.8290 USD
Purchase 2,034 204.6389 USD
Purchase 2,368 204.6150 USD
Purchase 2,816 204.5737 USD
Purchase 2,902 204.8425 USD
Purchase 3,094 204.3755 USD
Purchase 5,794 204.3000 USD
Purchase 7,995 204.4959 USD
Purchase 9,507 204.2997 USD
Purchase 19,275 204.4182 USD
Purchase 23,109 204.3308 USD
Purchase 42,790 204.2895 USD
Purchase 42,792 203.8537 USD
Purchase 43,715 204.5010 USD
Sale 1 204.1300 USD
Sale 1 203.9800 USD
Sale 1 204.7900 USD
Sale 1 204.8500 USD
Sale 1 204.2300 USD
Sale 2 204.0600 USD
Sale 2 204.0750 USD
Sale 2 202.4500 USD
Sale 4 204.1150 USD
Sale 4 204.7700 USD
Sale 4 204.0400 USD
Sale 4 202.7000 USD
Sale 4 204.2650 USD
Sale 6 204.4700 USD
Sale 8 204.4400 USD
Sale 12 203.6320 USD
Sale 19 204.6200 USD
Sale 54 204.1100 USD
Sale 72 205.2500 USD
Sale 100 203.8800 USD
Sale 100 204.1500 USD
Sale 100 204.5425 USD
Sale 104 202.6215 USD
Sale 200 204.1650 USD
Sale 200 204.7000 USD
Sale 213 203.7650 USD
Sale 272 203.8947 USD
Sale 300 204.7133 USD
Sale 300 204.8670 USD
Sale 308 204.1193 USD
Sale 433 204.4357 USD
Sale 438 204.3546 USD
Sale 484 203.6963 USD
Sale 501 203.9877 USD
Sale 514 204.3590 USD
Sale 1,045 204.2658 USD
Sale 1,156 204.5209 USD
Sale 1,169 204.3282 USD
Sale 1,246 204.4651 USD
Sale 1,258 204.2858 USD
Sale 1,259 204.1685 USD
Sale 1,314 205.5245 USD
Sale 1,465 204.4324 USD
Sale 1,779 204.0011 USD
Sale 3,181 203.6893 USD
Sale 3,370 204.5753 USD
Sale 3,453 204.2585 USD
Sale 3,916 204.4614 USD
Sale 4,000 204.4484 USD
Sale 4,093 204.4966 USD
Sale 4,553 204.4042 USD
Sale 4,623 204.7843 USD
Sale 6,933 204.6709 USD
Sale 6,987 204.5024 USD
Sale 9,496 204.2999 USD
Sale 13,994 204.3028 USD
Sale 14,128 204.4199 USD
Sale 14,535 203.5428 USD
Sale 14,987 204.4478 USD
Sale 17,291 204.1064 USD
Sale 17,760 204.0269 USD
Sale 18,486 204.4488 USD
Sale 18,602 204.7676 USD
Sale 22,790 204.3000 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 6 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210106005622/en/
(https://www.businesswire.com/news/home/20210106005622/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Gym Group PLC (The) Barclays PLC - Holding(s) in Company
AnnouncementREG - Entain PLC Barclays PLC - TR1: Notification of Major Holdings
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement